170 related articles for article (PubMed ID: 16034052)
1. Sentinel lymphadenectomy does not increase the incidence of in-transit metastases in primary melanoma.
Kang JC; Wanek LA; Essner R; Faries MB; Foshag LJ; Morton DL
J Clin Oncol; 2005 Jul; 23(21):4764-70. PubMed ID: 16034052
[TBL] [Abstract][Full Text] [Related]
2. A sentinel node biopsy does not increase the incidence of in-transit metastasis in patients with primary cutaneous melanoma.
van Poll D; Thompson JF; Colman MH; McKinnon JG; Saw RP; Stretch JR; Scolyer RA; Uren RF
Ann Surg Oncol; 2005 Aug; 12(8):597-608. PubMed ID: 16021534
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
[TBL] [Abstract][Full Text] [Related]
4. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
Thomas JM; Clark MA
Eur J Surg Oncol; 2004 Aug; 30(6):686-91. PubMed ID: 15256245
[TBL] [Abstract][Full Text] [Related]
5. Is there increased risk of local and in-transit recurrence following sentinel lymph node biopsy?
Cerovac S; Mashhadi SA; Williams AM; Allan RA; Stanley PR; Powell BW
J Plast Reconstr Aesthet Surg; 2006; 59(5):487-93. PubMed ID: 16631558
[TBL] [Abstract][Full Text] [Related]
6. Is incisional biopsy of melanoma harmful?
Martin RC; Scoggins CR; Ross MI; Reintgen DS; Noyes RD; Edwards MJ; McMasters KM
Am J Surg; 2005 Dec; 190(6):913-7. PubMed ID: 16307945
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymphadenectomy for staging patients with intermediate-level melanoma.
Smart KR; Cahoon BW; Dale PS
Am Surg; 2000 Mar; 66(3):280-3. PubMed ID: 10759200
[TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.
Doubrovsky A; De Wilt JH; Scolyer RA; McCarthy WH; Thompson JF
Ann Surg Oncol; 2004 Sep; 11(9):829-36. PubMed ID: 15313732
[TBL] [Abstract][Full Text] [Related]
9. High incidence of in-transit metastases after sentinel node biopsy in patients with melanoma.
Estourgie SH; Nieweg OE; Kroon BB
Br J Surg; 2004 Oct; 91(10):1370-1. PubMed ID: 15376178
[TBL] [Abstract][Full Text] [Related]
10. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
[TBL] [Abstract][Full Text] [Related]
11. Indications for lymphatic mapping and sentinel lymphadenectomy in patients with thin melanoma (Breslow thickness < or =1.0 mm).
Stitzenberg KB; Groben PA; Stern SL; Thomas NE; Hensing TA; Sansbury LB; Ollila DW
Ann Surg Oncol; 2004 Oct; 11(10):900-6. PubMed ID: 15383424
[TBL] [Abstract][Full Text] [Related]
12. Utility of computed tomography and magnetic resonance imaging staging before completion lymphadenectomy in patients with sentinel lymph node-positive melanoma.
Aloia TA; Gershenwald JE; Andtbacka RH; Johnson MM; Schacherer CW; Ng CS; Cormier JN; Lee JE; Ross MI; Mansfield PF
J Clin Oncol; 2006 Jun; 24(18):2858-65. PubMed ID: 16782925
[TBL] [Abstract][Full Text] [Related]
13. Re: Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma, Thomas and Clark.
Pawlik TM; Ross MI; Shaw HM; Thompson JF; Gershenwald JE
Eur J Surg Oncol; 2005 Apr; 31(3):323-4. PubMed ID: 15780572
[No Abstract] [Full Text] [Related]
14. In transit/local recurrences in melanoma patients after sentinel node biopsy and therapeutic lymph node dissection.
Rutkowski P; Nowecki ZI; Zurawski Z; Dziewirski W; Nasierowska-Guttmejer A; Switaj T; Ruka W
Eur J Cancer; 2006 Jan; 42(2):159-64. PubMed ID: 16324835
[TBL] [Abstract][Full Text] [Related]
15. Early recurrence after lymphatic mapping and sentinel node biopsy in patients with primary extremity melanoma: a comparison with elective lymph node dissection.
Clary BM; Mann B; Brady MS; Lewis JJ; Coit DG
Ann Surg Oncol; 2001 May; 8(4):328-37. PubMed ID: 11352306
[TBL] [Abstract][Full Text] [Related]
16. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
17. Previous wide local excision of primary melanoma is not a contraindication for sentinel lymph node biopsy of the trunk and extremity.
Leong WL; Ghazarian DM; McCready DR
J Surg Oncol; 2003 Mar; 82(3):143-6. PubMed ID: 12619055
[TBL] [Abstract][Full Text] [Related]
18. Predictors of survival and recurrence in the surgical treatment of merkel cell carcinoma of the extremities.
Senchenkov A; Barnes SA; Moran SL
J Surg Oncol; 2007 Mar; 95(3):229-34. PubMed ID: 17323336
[TBL] [Abstract][Full Text] [Related]
19. Selective lymphadenectomy in sentinel node-positive patients may increase the risk of local/in-transit recurrence in malignant melanoma.
Molenkamp BG; Statius Muller MG; Vuylsteke RJ; van der Sijp JR; Meijier S; van Leeuwen PA
Eur J Surg Oncol; 2005 Mar; 31(2):211-2. PubMed ID: 15698742
[No Abstract] [Full Text] [Related]
20. Sentinel lymph node biopsy in thin melanoma patients.
Hershko DD; Robb BW; Lowy AM; Ahmad SA; Ramadas GH; Soldano DA; Sussman JJ
J Surg Oncol; 2006 Mar; 93(4):279-85. PubMed ID: 16496355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]